Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 906804, 10 pages
http://dx.doi.org/10.1155/2014/906804
Research Article

Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells

1Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical College, Shangcai Village South, Ouhai District, Wenzhou, Zhejiang 325000, China
2Department of Gynecology, The Third Affiliated Hospital of Sun-Yat Sen University, Guangzhou, Guangdong 510632, China
3Department of Cell Biology and Institute of Biomedicine, College of Life Science and Technology, Jinan University, Room 708, The 2nd Engineer and Scientific Building, 601 Huangpu RoadWest, Guangzhou, Guangdong 510632, China

Received 14 February 2014; Revised 1 April 2014; Accepted 3 April 2014; Published 8 May 2014

Academic Editor: Si Jin

Copyright © 2014 Li-Hua Gong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Permuth-Wey and T. A. Sellers, “Epidemiology of ovarian cancer,” Methods in Molecular Biology, vol. 472, pp. 413–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Cannistra, “Cancer of the ovary,” The New England Journal of Medicine, vol. 351, no. 24, pp. 2519–2529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Chen, L. Liang, X. Yan et al., “Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer,” International Journal of Gynecological Cancer, vol. 23, no. 2, pp. 256–263, 2013. View at Publisher · View at Google Scholar
  4. X.-J. Yan, L.-Z. Liang, Z.-Y. Zeng, Z. Shi, and L.-W. Fu, “Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel,” Ai Zheng, vol. 25, no. 4, pp. 398–403, 2006. View at Google Scholar · View at Scopus
  5. X.-J. Yan, L.-Z. Liang, Z.-Y. Zeng, L.-W. Fu, and Z. Shi, “Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells,” Zhonghua Fu Chan Ke Za Zhi, vol. 40, no. 9, pp. 609–613, 2005. View at Google Scholar · View at Scopus
  6. X. J. Yan, L. H. Gong, F. Y. Zheng, K. J. Cheng, Z. S. Chen, and Z. Shi, “Triterpenoids as reversal agents for anticancer drug resistance treatment,” Drug Discovery Today, 2013. View at Publisher · View at Google Scholar
  7. C. K. Bose, “Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer,” Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, vol. 17, no. 5, pp. 231–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. P. Szatrowski and C. F. Nathan, “Production of large amounts of hydrogen peroxide by human tumor cells,” Cancer Research, vol. 51, no. 3, pp. 794–798, 1991. View at Google Scholar · View at Scopus
  9. P. T. Schumacker, “Reactive oxygen species in cancer cells: live by the sword, die by the sword,” Cancer Cell, vol. 10, no. 3, pp. 175–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Fang, T. Seki, and H. Maeda, “Therapeutic strategies by modulating oxygen stress in cancer and inflammation,” Advanced Drug Delivery Reviews, vol. 61, no. 4, pp. 290–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Q. Xue, J. M. Di, Y. luo, K. J. Cheng, X. Wei, and Z. Shi, “Resveratrol oligomers for the prevention and treatment of cancers,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 765832, 9 pages, 2014. View at Publisher · View at Google Scholar
  12. D. P. Bezerra, C. Pessoa, M. O. de Moraes, N. Saker-Neto, E. R. Silveira, and L. V. Costa-Lotufo, “Overview of the therapeutic potential of piplartine (piperlongumine),” European Journal of Pharmaceutical Sciences, vol. 48, no. 3, pp. 453–463, 2013. View at Publisher · View at Google Scholar
  13. D. P. Bezerra, G. C. G. Militão, F. O. de Castro et al., “Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways,” Toxicology in Vitro, vol. 21, no. 1, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. P. Bezerra, C. Pessoa, M. O. de Moraes et al., “Antiproliferative effects of two amides, piperine and piplartine, from Piper species,” Zeitschrift fur Naturforschung C: Journal of Biosciences, vol. 60, no. 7-8, pp. 539–543, 2005. View at Google Scholar · View at Scopus
  15. J. M. Liu, F. Pan, L. Li et al., “Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation,” Biochemical and Biophysical Research Communications, vol. 437, no. 1, pp. 87–93, 2013. View at Publisher · View at Google Scholar
  16. E.-H. Kong, Y.-J. Kim, Y.-J. Kim et al., “Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells,” Oncology Reports, vol. 20, no. 4, pp. 785–792, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. P. Bezerra, F. O. De Castro, A. P. N. N. Alves et al., “In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine,” Journal of Applied Toxicology, vol. 28, no. 2, pp. 156–163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Raj, T. Ide, A. U. Gurkar et al., “Selective killing of cancer cells by a small molecule targeting the stress response to ROS,” Nature, vol. 475, no. 7355, pp. 231–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. J. Adams, M. J. Dai, G. Pellegrino et al., “Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 38, pp. 15115–15120, 2012. View at Publisher · View at Google Scholar
  20. D. P. Bezerra, D. J. Moura, R. M. Rosa et al., “Evaluation of the genotoxicity of piplartine, an alkamide of Piper tuberculatum, in yeast and mammalian V79 cells,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 652, no. 2, pp. 164–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Makhov, K. Golovine, E. Teper et al., “Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death,” British Journal of Cancer, vol. 110, pp. 899–907, 2014. View at Publisher · View at Google Scholar
  22. Y. Wang, J. W. Wang, X. Xiao et al., “Piperlongumine induces autophagy by targeting p38 signaling,” Cell Death and Disease, vol. 4, p. e824, 2013. View at Publisher · View at Google Scholar
  23. Z. Shi, Y.-J. Liang, Z.-S. Chen et al., “Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo,” Cancer Biology & Therapy, vol. 5, no. 1, pp. 39–47, 2006. View at Google Scholar · View at Scopus
  24. C. S. Weil, “Tables for convenient calculation of median-effective dose (LD50 or ED50) and instructions in their use,” Biometrics, vol. 8, no. 1, pp. 249–263, 1952. View at Publisher · View at Google Scholar
  25. J. Fang, H. Nakamura, and A. K. Iyer, “Tumor-targeted induction of oxystress for cancer therapy,” Journal of Drug Targeting, vol. 15, no. 7-8, pp. 475–486, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D.-A. Silasi, A. B. Alvero, T. J. Rutherford, D. Brown, and G. Mor, “Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs,” Expert Opinion on Pharmacotherapy, vol. 10, no. 6, pp. 1059–1067, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ott, V. Gogvadze, S. Orrenius, and B. Zhivotovsky, “Mitochondria, oxidative stress and cell death,” Apoptosis, vol. 12, no. 5, pp. 913–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. Fruehauf and F. L. Meyskens Jr., “Reactive oxygen species: a breath of life or death?” Clinical Cancer Research, vol. 13, no. 3, pp. 789–794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Okuno, H. Sato, K. Kuriyama-Matsumura et al., “Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines,” British Journal of Cancer, vol. 88, no. 6, pp. 951–956, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. K. Maiti, “Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells,” The Pharmacogenomics Journal, vol. 10, no. 2, pp. 94–104, 2010. View at Publisher · View at Google Scholar · View at Scopus